CircRREB1 Mediates Metabolic Reprogramming and Stemness Maintenance to Facilitate Pancreatic Ductal Adenocarcinoma Progression
- 17 September 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 84 (24) , 4246-4263
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal tumor with limited treatment options and poor patient survival. Circular RNAs (circRNA) play crucial regulatory roles in the occurrence and development of various cancers, including PDAC. In this study, using circRNA sequencing of diverse PDAC samples, we identified circRREB1 as an oncogenic circRNA that is significantly upregulated in PDAC and is correlated with an unfavorable patient prognosis. Functionally, loss of circRREB1 markedly inhibited glycolysis and stemness, whereas elevated circRREB1 elicited the opposite effects. Mechanistically, circRREB1 interacted with PGK1, disrupting the association between PTEN and PGK1 and increasing PGK1 phosphorylation to activate glycolytic flux. Moreover, circRREB1 promoted WNT7B transcription by directly interacting with YBX1 and facilitating its nuclear translocation, consequently activating the Wnt/β-catenin signaling pathway to maintain PDAC stemness. Overall, these results highlight circRREB1 as a key regulator of metabolic and stemness properties of PDAC. Significance: CircRREB1 stimulates PGK1 to induce glycolysis and activates the Wnt/β-catenin signaling pathway to maintain stemness in pancreatic cancer, indicating the potential of circRREB1 as a biomarker and therapeutic target.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (U21A20374)
- National Natural Science Foundation of China (82072698)
- National Natural Science Foundation of China (82372906)
- Natural Science Foundation of Shanghai Municipality (23ZR1479300)
- Natural Science Foundation of Shanghai Municipality (23ZR1411900)
This publication has 48 references indexed in Scilit:
- Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcriptionJournal of Hepatology, 2022
- NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasisCell Metabolism, 2021
- A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistanceCellular Signalling, 2021
- PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatinDrug Development Research, 2021
- Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancerCancer Medicine, 2021
- Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapyLife Sciences, 2020
- Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signallingEBioMedicine, 2020
- Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic CancerCancer Cell, 2017
- Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008